Can Deferasirox dispersible tablets be reimbursed by medical insurance?

Deferasirox (Deferasirox) is a drug that treats iron overload. It is mainly used to treat iron overload in patients with hematological diseases caused by multiple blood transfusions. This drug belongs to a class of compounds called iron chelators, which help the body get rid of excess iron burden by binding to excess iron ions in the body.

Dedeferasirox dispersible tablets have been launched in China and have been included in medical insurance. Patients can purchase them domestically. The price of domestic specifications125mg*28 tablets is around 600 to 700. For specific prices and medical insurance reimbursement, please consult the local hospital pharmacy. There are original and generic deferasirox dispersible tablets in foreign countries. The original drug is mainly the Swiss Novartis original drug, and the price of 400mg*30 tablets is around 400 to 500; the generic drugs are mainly Indian generic drugs, and the specification of 400mg*30 tablets is about 300 to 400, and the ingredients of the original drug and generic drugs are basically the same.

Dispersible tablets of deferasirox are an oral preparation that are usually given to patients in tablet form. Its dispersible tablet formulation helps patients absorb the drug more easily into the body, improving the convenience of treatment. This is particularly important for patients who require long-term treatment.

This drug combines with free iron to form a water-soluble complex, allowing excess iron in the body to be excreted through urine and bile. This mechanism effectively alleviates the iron accumulation problem in patients' bodies caused by multiple blood transfusions and helps maintain normal iron balance.

However, patients need to closely monitor their liver and kidney function while taking deferasirox dispersible tablets, as the drug may have certain effects on these organs. In addition, regular checking of iron levels in the body is an important part of ensuring the effectiveness and safety of treatment.

Overall, deferasirox dispersible tablets, as a drug for the treatment of iron overload, provide an effective management method for patients with hematological diseases and help them maintain good health. However, caution still needs to be used under the guidance of a doctor during use to ensure the best therapeutic effect and patient safety.